Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Trimethoprim-sulfamethoxazole can cause aseptic meningitis.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

MicroRNA-21 could help diagnose and treat skin fibrosis.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.